Departments

Obstructive sleep apnea (January 2016)

David L. Keller, MD
Cleveland Clinic Journal of Medicine October 2016, 83 (10) 703; DOI: https://doi.org/10.3949/ccjm.83c.10001

TO THE EDITOR: Thanks for the concise review of obstructive sleep apnea (OSA) in the January 2016 issue.1 I offer the following comments and questions:

  1. Risk factors for OSA include large neck circumference, which in Table 1 is defined as larger than 40 cm (15.75 inches), which would include shirt collar sizes 16 and above. In the second paragraph of the text, large neck circumference is defined as greater than 17 inches in men, which would include collar sizes above 17. The definition of a large neck as larger than 40 cm must obviously be more sensitive for predicting OSA, and the definition of greater than 17 inches more specific. Which do the authors use in clinical practice?

  2. The American Academy of Sleep Medicine is quoted as recommending home OSA screening “if direct monitoring of the response to non-[continuous positive airway pressure] treatments for sleep apnea is needed.”2 However, the need for direct monitoring would seem to be a contraindication to home testing rather than an indication. If this statement is correct as written, would the authors explain why and how specific non-CPAP treatments for OSA are more amenable to monitoring at home than in the sleep lab?

  3. Patients with Parkinson disease are at risk for both OSA and hypotension, making them generally an exception to the association of OSA with hypertension.3

  4. The home overnight OSA test often consists of a pulse oximeter worn for 8 hours at night, taped to a finger.4 This simple, inexpensive test for OSA detects episodes of apnea or hypopnea that result in arterial desaturation. Is it beneficial to also document episodes of apnea or hypopnea that do not result in arterial desaturation? These episodes are included in the 17% false-negative rate for home OSA testing mentioned in the text. Are these episodes important clinically, other than for prognosis in patients who may go on to develop apneic episodes severe enough to cause desaturation?

  5. Lastly, the authors may wish to comment on the importance of diagnosing and treating OSA in patients who plan to have elective surgery under general anesthesia, which can lead to profound sleep apnea in the recovery room, with associated morbidity and death.5

REFERENCES

    1. Manne MB,
    2. Rutecki G
    . Obstructive sleep apnea: who should be tested, and how? Cleve Clin J Med 2016; 83:25–27.
    1. Collop NA,
    2. Anderson WM,
    3. Boehlecke B,
    4. et al
    5. Portable Monitoring Task Force of the American Academy of Sleep Medicine
    . Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007; 3:737–747.
    1. Sheu JJ,
    2. Lee HC,
    3. Lin HC,
    4. Kao LT,
    5. Chung SD
    . A 5-year follow-up study on the relationship between obstructive sleep apnea and Parkinson disease. J Clin Sleep Med 2015; 11:1403–1408.
    1. Lux L,
    2. Boehlecke B,
    3. Lohr KN
    . Effectiveness of portable monitoring devices for diagnosing obstructive sleep apnea: update of a systematic review. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep 01. www.ncbi.nlm.nih.gov/books/NBK299250/ Accessed August 31, 2016.
    1. Xará D,
    2. Mendonça J,
    3. Pereira H,
    4. Santos A,
    5. Abelha FJ
    . Adverse respiratory events after general anesthesia in patients at high risk of obstructive sleep apnea syndrome. Braz J Anesthesiol 2015; 65:359–366.